The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer
Crossref DOI link: https://doi.org/10.1245/s10434-020-08553-z
Published Online: 2020-05-09
Published Print: 2020-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Eby, Marcus E.
Seder, Christopher W.
Text and Data Mining valid from 2020-05-09
Version of Record valid from 2020-05-09
Article History
Received: 23 March 2020
First Online: 9 May 2020
Disclosure
: There are no conflicts of interest.